
The Urology Match has become increasingly competitive over the past decade, driving rising application numbers, interview inefficiencies, and growing financial and logistical burdens for both applicants and residency programs. The Society of Academic Urology (SAU) provides governance and administrative oversight of the Urology Match and in response, has implemented several quality improvements aimed at increasing transparency, efficiency, and equity across the match process. This manuscript summarizes these initiatives, and their impact on urology residency recruitment. Collectively major initiatives outlined in this manuscript have improved interview distribution, reduced unnecessary application burden, enhanced communication between applicants and programs, and provided data-driven insights to guide future policy changes. As the residency application landscape continues to evolve, ongoing evaluation of these initiatives and continued collaboration among applicants, residency programs, and national organizations will be essential to further refine the match process and increase transparency and effectiveness for both applicants and residency programs.
Stress urinary incontinence (SUI) secondary to intrinsic sphincter deficiency (ISD) remains a challenging condition in women with persistent or recurrent incontinence despite conservative or surgical treatment. Artificial urinary sphincter (AUS) implantation represents an established salvage option. This review summarizes recent evidence on clinical outcomes, evolving surgical approaches, quality-of-life outcomes, and emerging device technologies in women undergoing AUS implantation. A PubMed search of studies published between 2019 and 2025, conducted according to PRISMA 2020 guidelines, identified 30 eligible studies. Reported continence rates ranged from 59
This review examines the progress made in neuromodulation therapies for UUI since the original introduction of SNM devices until now. There are multiple current commercial neuromodulation therapies from which to choose, including those with sacral or tibial nerve targets. The intent is to provide critical evidence to help clinicians decide which device to offer their patients. Modern SNM systems consistently outperform both previous-generation SNM and contemporary iTNM. Modern SNM demonstrates substantially higher effectiveness than pooled averages including early device studies with outdated study designs, tools and implant techniques. Current iTNM outcomes are comparable to legacy SNM yet remain markedly lower than modern SNM. Contemporary data supports a clear hierarchy—modern SNM offers the highest effectiveness and the most favorable safety profile. We believe that our field is moving toward minimally invasive, highly targeted, patient-directed SNM systems—an evolution that aligns with both clinical outcomes and patient preferences.
Advancements in technology have been at the heart of endourology for decades. With the introduction of new and novel technologies, endourology is rapidly changing. This review aims to address the recent innovations and technological advances in endourology by addressing four different areas where tangible outcome improvements are being seen: (1) diagnostic and detection methods; (2) intraoperative optimisation and procedural automation; (3) prediction of treatment outcomes; and (4) the use of generative Artificial Intelligence (AI) and Large Language Models (LLMs) for patients’ education and monitoring. AI applications in endourology consistently demonstrate high diagnostic accuracy, with stone detection rates exceeding 95
To assess the diagnostic accuracy of novel imaging modalities in working up invasive bladder cancer prior to surgical management and their potential role in guiding treatment decisions. Multiple new imaging modalities, including VI-RADS and Biparametric MRI have been developed to better guide management of invasive bladder cancer. There lacks a comprehensive review of these modalities and their diagnostic performance. We performed a systematic review following PRISMA guidelines. PubMed, Embase, and Scopus were searched through 2025. Studies reporting sensitivity and specificity of novel imaging for muscle invasion detection or nodal staging were included. Quality assessment used the QUADAS 2 tool. Thirty three studies encompassing 4,689 patients were included. Twenty three studies evaluated the Vesical Imaging Reporting and Data System for muscle invasion detection, achieving median sensitivity of 94